Login / Signup

Treatment of children with refractory/relapse high risk langerhans cell histiocytosis with the combination of cytarabine, vindesine and prednisone.

Wenqian WangJian GeHonghao MaHongyun LianLei CuiYunze ZhaoZhigang LiTianyou WangRui Zhang
Published in: BMC pediatrics (2024)
A combination of Ara-c, VDS and prednisone was effective and safe for some patients with refractory/relapse MS-RO + LCH. The high-dose Ara-c regimen was associated with a numerically higher EFS rate.
Keyphrases
  • high dose
  • low dose
  • stem cell transplantation
  • free survival
  • mass spectrometry
  • acute myeloid leukemia
  • multiple sclerosis
  • young adults
  • single cell
  • cell therapy
  • ms ms
  • stem cells
  • mesenchymal stem cells